Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 13,501-13,512 of 23,847
Drug study icon
CompletedNCT02153502

AVP-786 for depression

This study is completed in the United States. It is testing AVP-786 for depression.

Multiple locations, including Birmingham
DepressionDrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression
Drug study icon
CompletedNCT05545111

Safety study of NBI-1117568 in schizophrenia

This study is completed in the United States. It is testing NBI-1117568 for schizophrenia.

Multiple locations, including Little Rock
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT02383095

Efficiency of Art-therapy in Psychotic Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Strasbourg
SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.